| Name | Steward Organization | Suggested Domain | Suggested Domain Description | Cde Group | Classification |
|---|---|---|---|---|---|
| This Participant received an Anti-Amyloid treatment. The use of an Anti-Amyloid treatment requires discontinuation of the study medication. | ADNI | Treatment |
Treatment for all conditions |
Other NIA-funded studies |
|
| # | Datatype |
|---|---|
|
|
Value List |
| # | Permissible value | Value meaning name |
|---|---|---|
|
|
1 | Yes - I confirm this participant has received an Anti-Amyloid Treatment. |
| # | Identifier | Origin | Version |
|---|---|---|---|
|
|
ADNI3_Anti-Amyloid Treatment Information_ANTIAMYTX_TXREC_NODD_CRF_VERSION | ADNI-PHASE+CRFNAME+TBLNAME+FLDNAME+DD_CRF_VERSION | ADNI_01-12-2025 |